Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human UNC5C ELISA Kit (AC2963)
Cat.#: ASET-1552
Specifications
Description Human UNC5C ELISA Kit allows for the in vitro quantitative determination of human UNC5C concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2486 Human Doublecortin ELISA Kit (AC3897) Quantitative inquiry ASET-2276 Human Calretinin ELISA Kit (AC3687) Quantitative inquiry ASET-2015 Human Visfatin ELISA Kit (AC3426) Quantitative inquiry ASET-2062 Human SLC26A4 ELISA Kit (AC3473) Quantitative inquiry ASET-1342 Mouse Prokineticin Receptor 1 ELISA Kit (AC2753) Quantitative inquiry ASET-1131 Human SOX2 ELISA Kit (AC2542) Quantitative inquiry ASET-1304 Human G-Protein Coupled Receptor 30 ELISA Kit (AC2715) Quantitative inquiry ASET-1974 Rat p75 NGF Receptor ELISA Kit (AC3385) Quantitative inquiry ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-1728 Porcine iNOS ELISA Kit (AC3139) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket